INDividualised EXercise for Kneecap Dislocations (INDEX-KD)

January 12, 2021 updated by: City, University of London

Individualised Exercise for Adults With an Acute Lateral Patellar Dislocation: a Feasibility Study

This study is a feasibility study. It will assess areas of uncertainty relating to the implementation of an individualised exercise programme for patients with a recent kneecap dislocation. This will help determine if a future larger study is feasible, and inform the design and conduct of future research that would aim to optimise outcomes after a kneecap dislocation.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The investigators aim to recruit 15 adult participants with a recent, first-time or recurrent kneecap dislocation, from an acute hospital. Participants will receive up to 6 physiotherapy sessions over 3 months. The investigator's exercise programme aims to improve leg muscle strength and facilitate a return to the participant's usual activities. This may include activities such as hopping and changing direction which differentiates it from other programmes. Participants will be required to perform the exercise programme 3 times a week independently. Strategies to increase adherence to the exercise programme will also be used. This study is part of a Masters in Clinical Research funded by the National Institute for Health Research

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oxford, United Kingdom, OX3 9DU
        • John Radcliffe Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • First time or recurrent lateral patella dislocation meeting the diagnostic criteria of 1) requiring reduction by paramedics or 2) diagnosed by a member of the trauma and orthopaedic team.

Exclusion Criteria:

  • Concurrent anterior cruciate ligament or posterior cruciate ligament injury confirmed by negative Lachman's and posterior drawer test or confirmed by Magnetic Resonance Imagery (MRI); medial collateral and lateral collateral ligament injury requiring application of a hinged knee brace or surgical repair; concomitant injury that would prohibit participation in the exercise intervention
  • > 4 weeks from injury to presentation to acute care (ED or trauma services)
  • Unable to give written informed consent
  • Previous surgery on the affected knee
  • Presence of fracture on plain radiograph including osteochondral fractures
  • Medial patellar dislocation
  • Considered inappropriate for referral to physiotherapy (by member of trauma and orthopaedic team assessing the patient)
  • History of severe neuromuscular or congenital disorders
  • Patients referred for orthopaedic opinion who are subsequently listed for surgery prior to completion of the study intervention
  • Unable to understand written or spoken English
  • Unable to attend physiotherapy sessions at the John Radcliffe trauma outpatient physiotherapy department

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Individualized exercise
Participants after a lateral kneecap dislocation will be enrolled into an individualized exercise intervention supervised by a physiotherapist
The intervention will be comprised of up to 6, one-to-one physiotherapy sessions, over a maximum duration of 3 months. 1 or 2 extra sessions are allowed if deemed essential by the participant's physiotherapist. Less than 6 physiotherapy sessions can be agreed with the participant if they have achieved their goals. Throughout this time participants will be required to perform an exercise programme a minimum of 3 times per week. The exercise programme aims to increase leg muscle strength and facilitate a return to the participant's usual activities. It may include hopping and change of direction tasks if these are activities the participant would normally do. Behavioural change techniques to increase participant adherence to the exercise programme will also be used.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Eligibility Rate
Time Frame: 15 weeks
Percentage of patients with a diagnosed lateral patellar dislocation, screened for eligibility, who satisfied the eligibility criteria
15 weeks
Recruitment Rate
Time Frame: 15 weeks
Percentage of eligible participants who consented to participate in the study
15 weeks
Attrition
Time Frame: 12 weeks
Percentage (0-100%) of participants enrolled in the study who failed to provide any 12 week follow-up data
12 weeks
Acceptability [Participant Satisfaction]: Questionnaire
Time Frame: 12 weeks
Participant response to an internally designed patient questionnaire. This will measure several domains of of intervention acceptability: satisfaction with treatment, self-efficacy, burden of treatment, and intention to adhere. 6 questions will assess satisfaction with treatment, 3 questions will assess self-efficacy,1 question will assess burden of treatment and 1 question will assess intention to adhere. Each question will use a 5 point likert scale (0-4) with lower scores indicating higher satisfaction, self-efficacy, and intention to adhere. Each question will be reported individually.
12 weeks
Adherence
Time Frame: 12 weeks
Percentage (0-100%) of scheduled physiotherapy sessions attended
12 weeks
Adherence [Participant-reported Adherence to Home Exercise Using a Likert Scale]
Time Frame: 12 weeks
Participant response at follow-up to the question 'how often did you perform your exercises at least three times a week?' using a five-point Likert scale (0-4) anchored at 'always' (0) and 'never' (4)
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability of Outcome Data Collection
Time Frame: 12 weeks
Percentage (0-100%) of questions completed in the following patient-reported outcome measures: Lysholm Knee Scoring Scale, Tegner Activity Scale, EQ-5D-5L, completed at baseline and returned at 3-month follow-up
12 weeks
Number of Treatment Related Adverse Events Experienced by Participants
Time Frame: Through 12 weeks after first physiotherapy session
The total number and type of treatment related adverse events experienced by participants will be recorded. This will be recorded from commencement of the intervention to 12 week follow-up. Treatment related adverse events will be recorded by physiotherapists at each physiotherapy session and by participant self report at 12 week follow up.
Through 12 weeks after first physiotherapy session
Presence/Absence of Common Lateral Patella Dislocation Diagnostic Criteria
Time Frame: Baseline
Following diagnosis of a lateral patellar dislocation by an orthopaedic surgeon or physiotherapist, the clinician will be asked which of the following proposed assessment findings to include in the eligibility criteria for future studies, were present/absent during their clinical examination: positive patella apprehension test, visible knee joint effusion or haemarthrosis, medial patellofemoral ligament tenderness on palpation, and a convincing patient history of a visible deformity on the lateral aspect of the knee or a sensation of the patella 'popping' out of joint followed by spontaneous reduction
Baseline
Tegner Activity Scale Questionnaire
Time Frame: 12 weeks
This measures activity on a scale from 0-10, with higher scores indicating higher activity. It will be administered as a patient completed questionnaire.
12 weeks
Lyhsolm Knee Scoring Scale Questionnaire
Time Frame: 12 Weeks
It is scored from 0-100 with lower scores indicating higher pain and disability. It will be administered as a patient completed questionnaire.
12 Weeks
Quality of Life Using the EQ-5D-5L Questionnaire
Time Frame: 12 weeks
This assess quality of life using 5 domains: mobility, self-care, usual activities, pain/discomfort and anxiety/depress, each containing 5 options. These domains are combined to give a single score ranging from -0.594 to 1 for UK populations, with higher scores indicating higher quality of life. Participants rate their overall health on a visual analogue scale from 0 (worst health you can imagine) to 100 (the best help you can imagine). It will be administered as a patient completed questionnaire.
12 weeks
Assess Delivery of the Intervention [Duration From Injury to Commencing Physiotherapy]
Time Frame: From date of injury until date of the first physiotherapy session, assessed up to 6 weeks
Treatment logs will be analysed to record the duration (number of days) from injury to commencing the intervention
From date of injury until date of the first physiotherapy session, assessed up to 6 weeks
Assess Delivery of the Intervention [Number of Physiotherapy Sessions Received by Participants]
Time Frame: 12 weeks
Treatment logs will be analysed to assess the number of physiotherapy sessions received by participants
12 weeks
Assess Delivery of the Intervention [Duration of Intervention]
Time Frame: 12 weeks
Treatment logs will be analysed to assess the duration (days) of the study intervention
12 weeks
Assess Delivery of the Intervention [Types of Exercises Prescribed by Physiotherapists]
Time Frame: 12 weeks
Treatment logs will be analysed to assess the types of exercise prescribed by physiotherapists to participants
12 weeks
Assess Delivery of the Intervention [Dose of Exercises Prescribed by Physiotherapists]
Time Frame: 12 weeks
Treatment logs will be analysed to assess the dose of exercise prescribed by physiotherapists to participants
12 weeks
Assess Delivery of the Intervention [Initial Injury Management]
Time Frame: From date of review by trauma and orthopaedic team until date of the first physiotherapy session, assessed up to 6 weeks
Treatment logs will be analysed to assess how participants are initially managed by trauma and orthopaedic team
From date of review by trauma and orthopaedic team until date of the first physiotherapy session, assessed up to 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mark Haddad, PhD, City, University of London

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 24, 2019

Primary Completion (Actual)

October 8, 2019

Study Completion (Actual)

October 15, 2019

Study Registration Dates

First Submitted

December 11, 2018

First Submitted That Met QC Criteria

January 8, 2019

First Posted (Actual)

January 10, 2019

Study Record Updates

Last Update Posted (Actual)

February 1, 2021

Last Update Submitted That Met QC Criteria

January 12, 2021

Last Verified

December 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • MRes/18-19/04/2
  • 251913 (Other Identifier: Health Research Authority - IRAS ID)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patella Dislocation

Clinical Trials on Individualised exercise

3
Subscribe